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Several studies suggest that normothermic ("warm") bypass techniques may 
improve myocardial outcomes for patients undergoing cardiac operations. 
Normothermic temperatures during cardiopulmonary b pass may, however, 
decrease the brain's tolerance to the ischemic insults that accompany all 
cardiac procedures. To assess the effect of bypass temperature management 
strategy on central nervous ystem outcomes in patients undergoing coronary 
revascularization, 138 patients were randomly assigned to two treatment 
groups: (1) hypothermia (n = 70), patients cooled to a temperature less than 
28 ° C during cardiopulmonary b pass, or (2) normothermia (n = 68), patients 
actively warmed to a temperature of at least 35 ° C. Patients underwent detailed 
neurologic examination before the operation, on postoperative days I to 3 and 
7 to 10, and at approximately 1 month after operation. In addition, abattery of 
five neuropsychologic tests was administered before operation, on postopera- 
tive days 7 to 10, and at the 4- to 6-week follow-up visit. Patients in the 
normothermic treatment group were older (65 ~- 10 vs 61 - 11 years in the 
hypothermic group), had statistically ess likelihood of preexisting cerebrovas- 
cular disease, and had higher bypass blood glucose values (276 - 100 rag/% vs .  
152 -+ 66 mg/% in the hypothermic group). All other patient characteristics 
and intraoperative ariables were similar in the two treatment groups. Seven 
of 68 patients in the normothermic group were found to have a central 
neurologic deficit, compared with none of the patients cooled to 28 ° C (p = 
0.006). Performance on at least one neuropsychologic test deteriorated in the 
immediate postoperative p riod in more than one half of all patients in both 
treatment groups but returned to preoperative l vels approximately 1 month 
after the operation in most (85%). This pattern was not related to bypass 
temperature management strategy. We conclude that active warming during 
cardiopulmonary b pass to maintain systemic temperatures >35 ° C increases 
the risk of perioperative neurologic deficit in patients undergoing elective 
coronary revascularization. (J Thorac Cardiovasc Surg 1996;112:514-22) 
[ n the early 1950s, Bigelow, Lindsay, and Green- 
1 |wood demonstrated that metabolic rate was 
linked to temperature and postulated that hypother- 
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mia could facilitate cardiac operations. Hypother- 
mia has since become the mainstay of organ protec- 
t ion-part icular ly for the heart and brain--during 
cardiopulmonary b pass (CPB). 2 Studies in the early 
1990s, however, suggested that normothermic car- 
dioplegia might enhance myocardial protection dur- 
ing cardiac operations, and "warm" techniques have 
since been widely adopted. 3-1° 
To date, several studies have assessed the effect of 
normothermic cardioplegia nd CPB on myocardial 
and neurologic outcomes in patients undergoing 
coronary revascularization. 6' 8,10, I1 Most investiga- 
tors agree that normothermic ardioplegia is an 
acceptable alternative myocardial protection strat- 
egy, but they differ with respect to findings of 
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neurologic outcomes associated with normothermic 
techniques. Martin and associates 8 demonstrated a 
substantially increased risk of neurologic dysfunc- 
tion in patients maintained at normothermic tem- 
peratures during CPB, whereas the Warm Heart 
Investigators (WHI) 1° and McLean and coworkers 11 
reported no increased risk of adverse neurolog- 
icl0, 11 or neuropsychologic 11 outcomes. 
Because even small fluctuations in brain temper- 
ature substantially affect the response to cerebral 
hypoxia, it is important o discriminate among var- 
ious CPB temperature management s rategies when 
considering the effect of normothermic versus hypo- 
thermic techniques on various outcomes. Several 
animal studies suggest hat even small increases in 
cerebral temperature (1 ° to 2 ° C) exacerbate isch- 
emic neuronal injury. 12-19 Cerebral temperatures of
38 ° to 39°C are associated with an increase in 
excitotoxic neurotransmitter release during cerebral 
hypoxia and with a delay in equilibration of intra- 
cellular high-energy phosphate metabolism. 17' 19 In 
contrast, mild hypothermia (temperature r duction 
of 2 ° to 4 ° C) has been shown to ameliorate cerebral 
ischemic damage. 12-14 Varying CPB techniques that 
include seemingly minor differences in target tem- 
peratures may thus result in profoundly different 
neurologic outcomes and quality of life after cardiac 
operations. 
This study was designed to determine whether 
patients undergoing coronary revascularization who 
are actively 'warmed during extracorporeal circula- 
tion to maintain systemic temperatures between 35 ° 
to 37°C have a higher incidence of perioperative 
central nervous ystem sequelae than those who are 
treated with hypothermic perfusion. Central ner- 
vous system morbidity was determined by both 
neurologic and neuropsychologic outcomes. 
Patients and methods 
Design. Of 1001 patients randomly assigned to undergo 
either hypothermic ornormothermic cardiac operations, a 
subset of 138 patients cheduled for coronary revascular- 
ization procedures was randomly assigned to receive 
either intermittent cold oxygenated crystalloid cardiople- 
gic solution during CPB with systemic hypothermia 
(-<28 ° C) (n = 70) or continuous normothermic blood 
retrograde cardioplegic solution during normothermic 
(->35 ° C) CPB (n = 68). Patients cheduled for concom- 
itant procedures (vascular surgery, valvular procedures, 
aneurysmectomy, repair of atrial or septal defects, or 
placement of internal defibrillators) or admitted to the 
operating room directly from the cardiac catheterization 
laboratory were excluded. The study protocol was ap- 
proved by the Emory University Human Investigations 
Committee, and informed consent was obtained from all 
participating patients. Treatments were randomly as- 
signed before operation by means of computer-generated 
random-numbers. Investigators performing the preopera- 
tive and postoperative assessments and the statistical 
analyses after completion of study were unaware of treat- 
ment group assignment. Only the pharmacist responsible 
for preparing the cardioplegic solutions (who opened a 
sealed envelope to ascertain study group assignment) and 
treating clinicians in the operating room and intensive 
care unit were aware of group assignment. 
Anesthesia techniques. Patients were medicated before 
the procedure with intramuscular morphine sulfate (0.07 
to 0.15 mg/kg) and either intramuscular midazolam hy- 
drochloride (0.02 to 0.05 mg/kg) or oral diazepam (0.10 to 
0.15 mg/kg). Anesthesia was induced with either intrave- 
nous fentanyl citrate (10 to 25 /xg/kg) or intravenous 
sufentanil citrate (2 to 5 /xg/kg) and Supplemental intra- 
venous doses of midazolam (0.05 to 0.10 mg/kg). Muscle 
relaxation was established and maintained with intermit- 
tent intravenous doses of pancuronium or vecuronium 
(0.1 to 0.4 mg/kg) throughout the operative period. Dur- 
ing CPB, anesthesia was maintained with supplemental 
doses of fentanyl, sufentanil, or isoflurane (0.25% to 1.0%), 
or with a propofol infusion (50 to 150 txg" kg -1" min-1). 
CPB and cardioplegic techniques. The myocardial pro- 
tection techniques used in this study have been described 
in detail elsewhere. 8 Briefly, in the normothermic group, 
high-potassium (100 mmol/L potassium chloride) blood 
cardioplegic solution (4:1 blood to crystalloid solution, 
final potassium concentration 24 mEq/L, temperature 
->35 °C) was infused in the aortic root at a rate of 100 to 
350 ml/min and a pressure of 100 to 300 mm Hg to achieve 
diastolic arrest. Subsequently, low-potassium (30 mmol/L 
potassium chloride) solution (temperature ->35 ° C) was 
administered continuously through a transatrial retro- 
grade coronary sinus catheter (Gundry Retroplegia Can- 
nula; DLP, Inc., Grand Rapids, Mich.). The remaining 
cardioplegic components (as described by Fremes) 
included 12 mmol/L trihydroxymethylaminomethane, 
9 mmol/L magnesium sulfate, 250 mmol/L dextrose, and 
20 mmol/L citrate-phosphate-dextrose-adenine. Coronary 
sinus pressures were maintained at approximately 40mm 
Hg, coronary sinus flow rates ranged from 40 to 250 
ml/min, and a negative-pressure vent was placed in the 
aortic root to permit return of cardioplegic solution. If 
necessary, retrograde infusion was interrupted briefly 
(<10 minutes) to permit optimal visualization of distal 
coronary anastomoses. Most proximal anastomoses were 
performed uring partial occlusion of the aorta. Systemic 
normothermia (bladder temperature ->35 ° C) was main- 
tained during CPB by means of a water-bath heater-cooler 
(Hematherm Sub-Zero, Cincinnati, Ohio), with bath tem- 
perature kept at a maximum of 40 ° C. 
In the hypothermic group, myocardial protection was 
achieved with intermittent cold oxygenated crystalloid 
cardioplegic solution (temperature -<8 °C) and externally 
applied cold crystalloid ice-slush solution. The cardiople- 
gic solution included 1000 ml Plasma-Lyte A (Baxter 
Healthcare Corp., Deerfield, Ill.), 25 mEq potassium 
chloride, 3 m150% dextrose, 20 mEq sodium bicarbonate, 
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and 8.6 ml 10% calcium gluconate. Initial myocardial 
arrest was achieved by infusing 1000 ml cardioplegic 
solution into the root of the crossclamped aorta at 150 to 
450 ml/min. Cardioplegic solution was intermittently ad- 
ministered through the coronary sinus aortic root, saphe- 
nous vein grafts, or both to maintain myocardial arrest 
and was reinfused every 15 to 20 minutes or if there was 
any evidence of myocardial activity. Distal anastomoses 
were placed during aortic occlusion and myocardial rrest; 
most proximal anastomoses were performed uring par- 
tial occlusion of the aorta. Systemic hypothermia (bladder 
temperature -<28 °C) was maintained throughout CPB 
with the use of a water-bath eater-cooler. Bladder tem- 
perature in both groups was monitored by means of a 
Foley catheter with temperature probe (Bard Urotrack 
Plus Foley; Bard Urological, Covington, Ga.). 
CPB techniques in both treatment groups included 
roller pumps (Cinco Heart-Lung Machines, Wakefield, 
Mass.), membrane oxygenators (Cobe Excel Adult Mem- 
brane Lung; Cobe Cardiovascular, Inc., Arvada, Colo.), 
arterial ine filters (30 /zm), and single aortic and atrial 
cannulation methods. Plasma-Lyte A was circulated 
through a5 mm prebypass filter to prime the pump circuit. 
Nonpulsatile pump flows were maintained at 2.2 to 2.5 
L. rain -1 • m 2 when the temperature was at least 32 ° C 
and as low as 1.8 L.  rain 1. m 2 when the temperature 
was less than 32 ° C. Mean arterial pressure was main- 
tained between 40 and 70 mm Hg; if necessary, vasocon- 
strictive drugs (phenylephrine, norepinephrine) were used 
to maintain perfusion pressure. Hypertension (mean ar- 
terial pressure >80 mm Hg) during CPB was treated by 
administration of anesthetic drugs (see Anesthesia Tech- 
niques) or sodium nitr0prusside. Moderate hemodilution 
(hematocrit 18% to 25%) and alpha-stat acid-base man- 
agement echniques were used. Oxygen inflow was ad- 
justed to maintain the oxygen tension between 250 to 350 
mm Hg and the systemic venous oxygen saturation at 70% 
or more during CPB. Anticoagulation was achieved with 
an initial 4.0 mg/kg dose of heparin; additional doses were 
administered to maintain the activated clotting time 
higher than 300 seconds (Hemochron 80; International 
Technidyne Corporation, Edison, N.J.) or heparin levels 
higher than 3 (Hemostasis Management System; Medtronic 
Cardiopulmonary, Anaheim, Calif.). 
The study protocol did not mandate any aspect of 
postoperative care. Decisions regarding patient care in the 
intensive care unit were made by the attending surgeon 
(who was aware of treatment group) and the intensive 
care unit physicians and other staff members (who were 
unaware of treatment assignment). 
Neurologic and neuropsychologic assessments. Neuro- 
logic examinations were performed by a single investiga- 
tor (M. B. H.) who was unaware of treatment group 
assignment during the four testing periods: preoperative, 
within 72 hours before the operation; postoperative, in- 
hospital days 1 to 3 and 7 to 10; and long-term, 4 to 6 
weeks. Neurologic assessment included an evaluation of 
mental status, motor and sensory function of cranial 
nerves II through XII and of the upper and lower extrem- 
ities, hand coordination, deep tendon reflexes, and prim- 
itive reflexes. Any new perioperative central neurologic 
deficits were diagnosed by fulfillment of any of the 
following criteria: (1) altered level of consciousness or 
confusion (not attributable to pharmacologic or metabolic 
causes), (2) impaired speech, (3) visual disturbances, or 
(4) new or worsened motor or sensory deficits of the face 
or upper and lower extremities (not attributable to pe- 
ripheral esions). The preoperative neurologic evaluation 
served as the baseline for this determination. 
Neuropsychologic testing was conducted for 109 pa- 
tients who consented to undergo cognitive function testing 
in addition to neurologic evaluation. Preoperative neuro- 
psychologic testing was performed within 72 hours before 
the operation, postoperative t sting was performed in the 
hospital at 7 to 10 days after the operation, and long-term 
testing was performed at 4 to 6 weeks. The following 
battery of five tests was used: (1) Mental control test, (2) 
associate learning test (both tests 1 and 2 are subtests of 
the Wechsler Memory Scale [WMS]), 2° (3) digit span test, 
(4) digit symbol test (both tests 3 and 4 are subtests of the 
Wechsler Adult Intelligence Scale, Revised [WAIS-R]), 21 
and (5) grooved pegboard test. These tests were selected 
because of their sensitivity to the neurologic deficits that 
occur in the cerebral domains most vulnerable to injury 
after cardiac operations: concentration and attention, 
auditory memory and new learning ability, immediate 
auditory memory span, psychomotor function, fine motor 
dexterity, and tracking. All neuropsychologic tests were 
administered and scored according to standard proce- 
dures by one of two investigators (M. B. H., P. A. B.) who 
remained unaware of treatment group assignment. 
To further evaluate the effect of CPB temperature 
management s rategy on perioperative neuropsychologic 
performance, the number of patients in each treatment 
group with either improvement or decrement in any 
neuropsychologic test score was noted. A postoperative 
change was considered significant if the difference in score 
for a given test exceeded the preoperative standard evi- 
ation for that test. 
Statistical methods. All data were collected on stan- 
dardized forms, entered into a computerized atabase, 
and analyzed with BMDP Software (Los Angeles, Calif.). 
Results are reported as means (_+ the standard eviation) 
or proportions. Continuous measures were compared with 
unpaired t tests, and categoric measures were compared 
by X a statistical analyses or Fisher's Exact Test as appro- 
priate. Repeated measures were analyzed with two-way 
analysis of variance. A p value lower than 0.05 was 
considered to indicate statistical significance. 
Results 
The study protocol was completed for all 138 
patients. Preoperative patient characteristics in the 
two treatment groups are shown in Table I. The 
normothermic group had significantly higher mean 
age (p = 0.03) despite similar percentages of pa- 
tients older than 60 years in the two treatment 
groups (p = 0.21), and the hypothermic group 
tended to have a higher prevalence of previous 
stroke (/9 = 0.10). Of the intraoperative variables 
(Table II), only glucose concentration during CPB 
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differed significantly between the treatment groups 
(p < 0.001); it was higher in normothermic patients 
despite similar ates of insulin administration during 
CPB in the two treatment groups. The retrograde 
infusion of cardioplegic solution was interrupted to 
facilitate the placement of the distal coronary anas- 
tomoses in fewer than 10% of the patients in the 
normothermic group. 
Neurologic outcomes. Seven of 138 patients were 
found to have a new perioperative central neuro- 
logic deficit (hypothermic group n = 0, normother- 
mic group n = 7, p = 0.006). Six of these seven 
patients had nonfatal focal lesions consistent with a 
central neurologic deficit, and the seventh patient 
failed to regain consciousness and died on postop- 
erative day 2 of a cerebral infarction. 
Neuropsyc]hologic outcomes. One hundred nine 
patients participated in neuropsychologic evalua- 
tion. Results are provided in Table III. There was a 
significant change in test performance on all the 
neuropsychologic tests with time (p < 0.001 for all 
five tests), but the change was not specific to treat- 
ment group. There was a trend toward a group effect 
in the digit span (p = 0.07) and mental control (p = 
0.06) tests, however, with the hypothermic group 
tending to perform better on these two tests with 
time. Scores on the associate l arning (WMS), men- 
tal control (WMS), digit symbol (WAIS-R), and 
grooved pegboard tests deteriorated similarly in the 
immediate postoperative period in the two treat- 
ment groups; however, there was a greater decre- 
ment in performance on the digit span test 
(WAIS-R) in the normothermic group (Table III). 
At the 4- to 6-week follow-up, all group test scores 
had returned to preoperative values (associate 
learning [WMS] and mental control [WMS]) or 
significantly improved (digit span and symbol 
[WAIS-R], and grooved pegboard) in both treat- 
ment groups. 
Many patients were unwilling to complete all the 
postoperative and follow-up neuropsychologic tests, 
but there was no difference in the number of pa- 
tients in each group completing specific tests. Six of 
the seven patients found to have a central neuro- 
logic deficit underwent europsychologic testing be- 
fore discharge from the hospital, and four completed 
the 4- to 6-week follow-up tests. Because xclusion of 
the data from these seven patients did not affect he 
analysis of the neuropsychologic outcome data, these 
data were included in this study set. 
The numbers of patients with improvement or 
decrement in neuropsychologic test scores did not 
Table I. Patient demographics 
Hypothermic Normothermic 
group group 
Variable (n = 70) (n = 68) p 
Age (yr)* 61 -+ 11 65 _+ 10 0.03 
Age >60 yr (%) 56 68 0.21 
Gender (% female) 19 25 0.47 
Previous troke (%) 12 3 0.10 
Diabetes (%) 27 24 0.70 
Hypertension (%) 57 59 0.84 
Previous CABG (%) 9 13 0.54 
*Mean -- standard eviation. 
differ between the treatment groups in either of the 
postoperative t sting periods (Table IV). In the 
immediate postoperative p riod, more than half of 
all patients had a significant deterioration i  at least 
one neuropsychologic test score and few patients 
demonstrated any improvement in performance on 
any measure. In comparison with their preoperative 
test performance, at the 4- to 6-week follow-up 
assessment, 72% of patients achieved neuropsycho- 
logic test scores imilar to their preoperative r sults, 
13% showed significant improvement, and 15% had 
a significant deterioration i  at least one neuropsy- 
chologic test score. 
Discussion 
These data support he hypothesis that warming 
of patients during CPB to maintain the systemic 
temperature at35°C or more increases the risk of 
neurologic deficits after coronary revascularization 
procedures. In this 138-patient study, seven of 68 
patients in the actively warmed group had evidence 
of a new central neurologic deficit, compared with 
none of 70 patients who underwent operation with 
hypothermic CPB. In the light of the overall preva- 
lence of central neurologic deficits in this surgical 
population between 2.5% and 5%, 22,23 the 10% 
incidence of new neurologic dysfunction in the 
normothermic group is of substantial concern. 
In contrast to neurologic outcome, CPB temper- 
ature management s rategy did not substantially 
influence performance on postoperative neuropsy- 
chologic tests. In the immediate postoperative p - 
riod, performance deteriorated on at least one neu- 
ropsychologic test in more than half of all patients in 
both treatment groups. During the 4- to 6-week 
follow-up assessment, performance r turned to pre- 
operative l vels in most patients, but 15% continued 
to manifest deterioration on at least one neuropsy- 
chologic test. 
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Table II. lntraoperative variables 
Variable Hypothermic group Normothermic group p 
Crossclamp time (min)* 36 _+ 12 (14-69) 37 + 14 (12-79) 0.48 
CPB time (min)* 86 -+ 26 (39-167) 82 _+ 23 (35-135) 0.35 
Glucose (mg/dl)* 152 _+ 66 (88-429) 276 + 100 (100-546) <0.001 
Insulin (%) 16 22 0.22 
IABP (%) 3 3 1.0 
*Mean _+ standard eviation; range in parentheses. IABP, Intraaortic balloon pump. 
Table IIL Intergroup comparison of neuropsychologic test results 
Preoperative (0 to 3 days) Postoperative day 7 to 10 
Hypothermic Normothermic Hypothermic Normothermic 
Test Mean n Mean n p Mean n Mean n 
4- to 6-week follow-up 
Hypothermic Normothermic 
p Mean n Mean n p 
Associate learning 12 _+ 4 54 12 _+ 3 55 NS 8 -+ 3 43 9 _+ 3 43 NS 12 _+ 4 39 12 _+ 4 45 NS 
(WMS) 
Mental control 6 -+2 54 6_+2 55 NS 6 -+2 47 5 +2 45 NS 7 -+2 39 6 +2 45 NS 
(WMS) 
Digit span 14_+4 54 13_+4 55 NS 14 +4 47 12_+3 45 0.001 16+5 39 14_+4 45 0.1 
(WAIS-R) 
Digit symbol 36_+12 51 31_+13 55 NS 30-13  43 25_+14 45 NS 41_+13 37 35_+15 45 NS 
(WAIS-R) 
Grooved pegboard 133_+43 51 138-+53 54 NS 147_+50 41 162+_62 44 NS 122_+46 38 129+_48 44 NS 
All values reported as mean -- standard eviation. With the exception of the grooved pegboard test results, higher scores indicate better performance. NS, 
Not significant. 
Table IV. Number of patients in each group with no change, significant improvement, or significant decrement 
in neuropsychologic test scores with time 
Before operation to POD 7-10 Before operation to 1-month follow-up 
No change Improvement Decrement No change Improvement Decrement 
Testing period H N H N H N H N H N H N 
Associate learning (WMS) 19 22 1 0 23 21 32 36 4 5 3 4 
Mental control (WMS) 35 40 2 2 10 3 33 36 4 7 2 2 
Digit span (WAIS-R) 33 39 6 4 8 2 33 38 1 2 5 5 
Digit symbol (WAIS-R) 39 38 0 0 4 7 36 42 1 3 0 0 
Grooved pegboard 37 38 0 0 4 6 35 37 2 5 1 2 
Total 163 178 9 6 49 39 169 189 12 22 11 13 
Performance differences between testing periods were considered significant when the subject's test score fluctuated more than one preoperative group 
standard eviation for that test. No significant difference between the two treatment groups was detected in any test for either postoperative testing period. 
POD, Postoperative day; NS, not significant. 
During cardiac operations and CPB, the brain is 
subjected to an almost continuous shower of both 
macroemboli (>200 ~m) and microemboli. Athero- 
sclerotic plaques, blood thrombi, platelet aggre- 
gates, fat globules, inorganic debris from the CPB 
circuit, and air and anesthetic gases form both large 
and small emboli that may result in temporary 
cerebral ischemia or infarction. Cerebrovascular 
macroembolization, especially atheroembolism, is 
believed to be responsible for gross and focal neu- 
rologic deficits after cardiac operations 24' 25--post- 
mortem review of brains from 129 patients who died 
after cardiac surgical procedures demonstrated a 
significantly higher prevalence of stroke before 
death among patients with evidence of atheroemboli 
(51%) than among those without evidence of athe- 
roemboli (18%). 25 The clinical effects of microem- 
bolization may go unnoticed, may be seen as a 
diffuse pattern of neurologic injury, or may contrib- 
ute to the neuropsychologic dysfunction observed 
after CPB. 26' 27 Specifically, the severity of postop- 
erative neuropsychologic deficits appears to corre- 
late well with the number of microemboli observed 
with ultrasonography. 26' 27 The precise etiology of 
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neuropsychologic dysfunction i  cardiac surgical pa- 
tients is unknown, however; cerebral inflammation, 
perioperative medications and a myriad of other 
factors may influence performance on neuropsycho- 
logic examinations. 
Swain 2 characterized the use of hypothermia dur- 
ing CPB as "the current mainstay of cerebral pro- 
tection," and substantial evidence demonstrates the 
cerebral protective ffects of hypothermia during tem- 
porary focal or global cerebral ischemia] 214' 18, 28-31 
Hypothermia reduces cellular metabolism, which 
limits energy substrate and oxygen consumption, 
thereby increasing cellular tolerance to dimin- 
ished blood flow and oxygen delivery. 32 In addi- 
tion, hypothermia meliorates the ischemia-in- 
duced increase in excitotoxic neurotransmitters 
(most notably glutamate) that amplify ischemic 
damage after cell failure to produce high-energy 
triphosphates. 33 In a nonbypass animal model of 
temporary ischemia, Busto and colleagues 2 dem- 
onstrated that maintaining brain temperature at 
30 ° to 330C completely inhibited the release of 
glutamate and significantly attenuated the release 
of dopamine. Even small decrements in cerebral 
temperature: thus confer protection. Finally, hy- 
pothermia lso reduces the cellular acidosis that 
accompanies i chemia 13 and has a palliative effect 
on the development of edema, possibly by main- 
taining the imtegrity of the blood-brain barrier. 34 
The protective effects of hypothermia re less 
clear for the permanent lesions (such as aortic 
atheroma) that are probably responsible for much of 
the cerebral ischemia ccompanying cardiac opera- 
tions. 19'31'3s Ridenour and coworkers 31 reported 
that mild hypothermia (33 ° C) did not reduce the 
volume of cerebral infarction in rats with a perma- 
nent focal lesion, whereas Onesti and associates 35
demonstrated that deep hypothermia (24 ° C) effec- 
tively limited cerebral infarction in a similar model. 
Morikawa and colleagues 18found that manipula- 
tions of brain temperature had a greater effect in 
rats subjected to reversible ischemic lesions but also 
found that even moderate hypothermia (30 ° C) 
tended to reduce cerebral infarct volume in rats with 
permanent lesions. On the basis of these animal 
data, our use of a hypothermic CPB technique 
(28 ° C) may have provided protection from both 
temporary and permanent ischemic insults. 
Several studies suggest hat manipulation of the 
aorta is associated with embolization of atheroma- 
tous material to the cerebral circulation. 24 In this 
study, both treatment groups had similar systemic 
temperatures (35 ° C to 37 ° C) at the time of maxi- 
mum aortic manipulation (during the application of 
the crossclamp), suggesting that the absence of 
neurologic deficits in the hypothermic group might 
not be related to the temperature of the patient 
after crossclamp application. The institution of hy- 
pothermia after an ischemic insult, however, also 
may be protective. 36'37 Zhang and colleagues 37
demonstrated that perfusion with hypothermic 
blood (30 ° C) after a 2-hour normothermic schemic 
insult reduced cerebral infarction volume in a rat 
model of temporary cerebral ischemia. 
It is unclear why hypothermia did not limit the 
neuropsychologic dysfunction identified in the 
patients managed with CPB at 28 ° C. Although 
cerebral emboli resulting in vascular occlusion 
and ischemia re thought o be a possible cause of 
neuropsychologic deficits in patients undergoing 
cardiac operations, other mechanisms, such as 
changes in cerebral microcirculation and coagula- 
tion, may contribute to postoperative neuropsycho- 
logic dysfunction. For example, cerebral air emboli 
damage pial vessel endothelium, leading to the 
disruption of vasoreactivity and ultrastructural b- 
normalities. 38Even in the absence of mechanical 
blockage of the microvasculature, air emboli can 
disrupt normal cerebral microcirculation. One could 
speculate that the changes induced by air microem- 
boli may contribute to the neuropsychologic dys- 
function observed after CPB. These microvascular 
processes may not be influenced by temperature in
the same manner as ischemic phenomena initiated 
by the mechanical obstruction of the cerebral micro- 
circulation. In summary, the processes responsible 
for gross neurologic deficits after cardiac operations 
probably differ from those causing neuropsychologic 
dysfunction and may be affected by temperature in a 
different manner. 
Factors that may have contributed to our finding 
of increased risk of adverse neurologic outcome in 
our normothermically managed patients include 
age, criteria for inclusion and for risk, and a rigor- 
ously controlled study protocol. The risk of adverse 
neurologic outcomes increases with age, 39 and as- 
pects of the different modes of delivery of cardiople- 
gic solution may have increased the embolic load to 
the brain. Additionally, patients who were actively 
warmed during CPB were exposed to higher blood 
concentrations of glucose than patients cooled to 
28 ° C, and several animal studies uggest that hyper- 
glycemia exacerbates both global and focal neuro- 
logic ischemic injury. 40'41 That is, the anaerobic 
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metabolism of glucose potentiates the excitotoxic 
cascade that causes neurologic injury. 42 Mild (32 ° to 
33 ° C) and moderate hypothermia (30 ° C) limit both 
the neurologic and histologic manifestations of hy- 
perglycemia n neuronal ischemia, 43' 44 and studies 
in patients undergoing hypothermic CPB suggest 
that hyperglycemia during CPB does not worsen 
neurologic injury after cardiac operations. 45 Al- 
though McLean and coworkers 11 also noted signifi- 
cantly higher blood glucose concentrations in their 
"warmed" patients without increased risk of stroke, 
their failure to control for "drift" (the spontaneous 
loss of body heat during CPB) in the tested temper- 
ature range precludes their ability to find any reli- 
able associations among hyperglycemia, normother- 
mia, and outcome. Perhaps the increased prevalence 
of neurologic deficits found in our normothermic 
group was not the result of temperature manage- 
ment strategy but rather of the hyperglycemic milieu 
present during a period (CPB) when a cerebral isch- 
emic insult was likely. Alternatively, normothermic, 
hyperglycemic conditions during CPB may have had 
an additive or synergistic adverse ffect on neurologic 
outcome in the normothermic treatment group. 
Because we actively warmed our normothermic 
patients to maintain abladder temperature b tween 
35 ° and 37 ° C, it is possible that many if not all had 
cerebral temperatures that were not normothermic 
but were in fact hyperthermic (>37 °C). The CPB 
circuit water bath was maintained at39 ° to 40 ° C, so 
the blood infused into the aortic root may have had 
a temperature greater than 37 ° C. Several animal 
studies demonstrate that even small (2 ° C) increases 
in brain temperature can exacerbate neuronal in- 
jury. Dietrich and associates 16 demonstrated that 
the histopathologic consequences of temporary 
global forebrain ischemia were significantly worse in 
rats maintained at39 ° C than in those maintained at
37 ° C; they subsequently found that mild intraisch- 
emic hyperthermia (39 ° C) exacerbated pathologic 
changes in blood-brain barrier permeability. 34 Sim- 
ilarly, Mitani and Kataoka 17 found that increasing 
cerebral temperatures in gerbils from 37 ° C to 39 ° C 
during temporary global ischemia significantly in- 
creased both postischemic release of glutamate and 
mortality. Our study results thus may not suggest 
that hypothermia per se protects against ischemic 
cerebral injury during CPB as much that hyperther- 
mia potentiates ischemic pathologic processes in the 
brain during cardiac operations. 
Comparison with other studies. Several studies 
have reported on neurologic outcomes in patients 
undergoing cardiac procedures with varying types of 
normothermic temperature management strategies 
during CPB. 6' s, 10, 11 Our results are consistent with 
those obtained by Martin and associates s in their 
study of hypothermic versus normothermic tech- 
nique in a group of 1001 patients, of which our 138 
patients form a specific subset. Although preopera- 
tive and postoperative neurologic examinations 
were not performed in the series of Martin and 
associates 8 (limiting the ability to detect postopera- 
tive adverse neurologic events), the normothermic 
technique increased the risk for adverse neurologic 
outcomes (4.5% versus 1.4% in the hypothermic 
group). Importantly, only three of the seven adverse 
neurologic events identified in this study's popula- 
tion were discovered by the chart review methods 
used by Martin and associates. 8 Additionally, all 
patients found by Martin and associates s to have a 
postoperative adverse neurologic event were simi- 
larly identified in this study. Sotaniemi, Juolasmaa, 
and Hokkanen 46 reported that study methods that 
depend on retrospective chart review to identify 
clinical events grossly underestimate the prevalence 
of postoperative adverse neurologic events. 
Our results do not reflect hose reported by Singh 
and colleagues, 6 the WHI, 1° or McLean and co- 
workers. 11 Of these three groups of investigators, 
only Singh and colleagues 6 consistently warmed 
patients during CPB, maintaining the temperature 
of the bladder at 36 ° C and that of the perfusate at 
37 ° C. Myocardial protection was provided by hypo- 
thermic ardioplegic solution and iced saline solu- 
tion slush in the pericardial sac. It is possible that 
this protection technique reduced the local temper- 
ature of the blood pumped through the aorta and to 
the cerebral circulation, thereby limiting the brain's 
exposure to normothermic blood temperatures. 
Their finding of surprisingly few strokes (1%) in a 
population undergoing open-chamber and closed- 
chamber cardiac procedures may also reflect a fail- 
ure to perform preoperative n urologic assessments. 
Without a baseline assessment, the extent of neuro- 
logic dysfunction would be difficult to quantify. 
The WHI 1° and McLean and coworkers 11 (study- 
ing a subgroup from the WHI study) both reported 
that normothermic CPB does not increase the risk 
of adverse neurologic events in patients undergoing 
coronary artery bypass grafting. The respective 
prevalences of stroke in the normothermic and 
hypothermic groups were 1.6% and 1.5% in the 
WHI trial 1° and 2.6% and 5.2% in the study of 
McLean and coworkers. 11There are, however, sev- 
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eral important differences between those studies 
and this one. Most important, neither the WHI  ~° 
nor McLean and coworkers 1~ were consistent in 
studying a single temperature management s rategy. 
Some patients were actively warmed to 37 ° C, but 
others were allowed to "drift" to systemic tempera- 
tures of 33 ° to 36 ° C. Second, also unlike this study, 
patients with an increased risk of a perioperative 
adverse neurologic event (patients with a preopera- 
tive history of carotid stenosis or stroke) were not 
included in either previous study. Yet patients with 
symptomatic erebrovascular disease have an in- 
creased risk of perioperative stroke. 47' 48 Third, the 
mean ages of patients in the studies of the WHI  1° 
and McLean and coworkers u were substantially 
lower (about 58 years) than that of our patients 
(about 63 years), and advanced age has been re- 
ported to increase the risk of adverse neurologic 
outcome for patients undergoing coronary opera- 
tions. 39 Fourth, in contrast to the practice of the 
WHI  group, m in this study a partially occluding 
aortic clamp was placed in most patients to facilitate 
the placement of the proximal coronary artery vein 
grafts. This manipulation may have increased the 
embolic load to the brain. Perhaps patients in the 
hypothermic group tolerated this additional insult, 
whereas those in the normothermic group were 
unprotected by reduced cerebral temperatures. Fi- 
nally, the WHI  group 1° became aware of the finding 
of Martin and associates 8 of an association between 
normothermic CPB and adverse neurologic events 
in the midst of their study, and they immediately 
terminated their active warming protocol to avoid 
patient risk. Although these differences make it 
difficult to compare our results with those of these 
investigators, it may be reasonable to suggest hat 
overall their patients were at less risk for a periopera- 
tive neurologic deficit because of less conducive pre- 
operative demographic characteristics and a tendency 
toward lower cerebral temperatures during CPB. 
Because the brain is vulnerable to ischemic injury 
during cardiac surgery and CPB, clinicians must 
carefully consider the factors that can limit or 
potentiate the pathophysiologic processes that result 
in cerebral damage. In this study, patients in the 
normothermic group may have been exposed to 
arterial blood with a temperature in excess of 37 ° C. 
This phenomenon could be expected to increase the 
risk of adverse neurologic outcome. Although nor- 
mothermic myocardial protection techniques may 
be desirable in certain patient groups, the CPB 
technique s]hould not expose the brain to an unnec- 
essary temperature or heat load. This study demon- 
strates that patients undergoing coronary revascu- 
larization should not be actively warmed during 
CPB to maintain bladder temperatures between 35 ° 
and 37 ° C because that technique increases the risk 
of stroke in this group of patients. Several investi- 
gators are now studying the effect of "tepid" or 
"lukewarm" CPB temperature management on 
myocardial outcomes. Perhaps these and future 
studies will define the optimal temperature manage- 
ment strategy to protect both the heart and the brain 
during cardiac operations. 
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